FDA developing new rules for artificial intelligence in medicine

It’s very encouraging to see the FDA showing forward thinking when it comes to AI/ML-based diagnostics. Even the best model can be outdated quickly given the changing data landscape, making frameworks like Augusta that allow for model refinement and evolution to be crucial. We welcome this mindset as we work with our partners to build more interpretable and more adaptable diagnostic models.https://www.statnews.com/2019/04/02/fda-new-rules-for-artificial-intelligence-in-medicine/

Previous
Previous

MEDIA ALERT: BioSymetrics to Demonstrate Usage of Artificial Intelligence for Healthcare and Biomedical R&D Innovation at Collision 2019

Next
Next

'Contingent AI', What is it?